One thing that is still open after anders_CPH’s answer:
How much of the between-person variation is pharmacokinetic and how much is just adherence measured badly?
One thing that is still open after anders_CPH’s answer:
How much of the between-person variation is pharmacokinetic and how much is just adherence measured badly?
NauseaFreeNow said:Six weeks on from posting: I stopped reading the weekly number and started reading a four-week average, and the "stall" I opened this thread about was…
I am going to disagree with the direction of travel here. The thread has converged on the tidiest answer rather than the best-supported one, and those are not the same thing.
Happy to go further on any of that.
NauseaFreeNow said:Six weeks on from posting: I stopped reading the weekly number and started reading a four-week average, and the "stall" I opened this thread about was…
Agreed on the substance. I would put less weight on the timescale, because two months of anything is not enough to distinguish a trend from a wobble.
Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.
Shop Reference StandardsNauseaFreeNow said:Six weeks on from posting: I stopped reading the weekly number and started reading a four-week average, and the "stall" I opened this thread about was…
This answered a question I did not know how to ask.
Clinical perspective, offered as context rather than as advice. It helps to say which part of this you are uncertain about. A precise question gets a precise answer; a general one gets everybody’s favourite anecdote.